Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-04-12
2011-04-12
Burkhart, Michael (Department: 1633)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S320100, C435S325000, C435S006120, C800S003000
Reexamination Certificate
active
07923545
ABSTRACT:
The present invention relates to a new family of structurally and functionally related nucleic acids and proteins, designed the CATERPILLER family, which is characterized by landmark structural motifs including a nucleotide binding domain and leucine-rich repeat domains.
REFERENCES:
patent: 6432442 (2002-08-01), Bertin et al.
patent: 2001/0029033 (2001-10-01), Shami et al.
patent: 2003/0027757 (2003-02-01), Bertin et al.
patent: 2004/0253615 (2004-12-01), Inohara et al.
patent: 2009/0291450 (2009-11-01), Ting et al.
patent: WO 01/04307 (2001-01-01), None
GenBank Acc. No. AC090160.6, “Homo SapiensChromosome 11, Clone RP11-431N10, Complete Sequence” US National Library of Medicine, Aug. 23, 2002, accessed by PTO Jan. 19, 2007 (includes first sheet of AC090160.1, published Feb. 17, 2001).
GenBank Acc. No. AC004644, “Homo SapiensChromosome 16, Cosmid Clone 367E12 (LANL), Complete Sequence” US National Library of Medicine, May 1, 1998, accessed by PTO Jan. 19, 2007.
GenBank Acc. No. AF410477,Homo SapiensCryopyrin (CIAS1) mRNA, Complete CDs, Alternatively Spliced, US National Library of Medicine, Nov. 21, 2001, accessed by PTO Jan. 19, 2007.
Kennell. “Principles and Practices of Nucleic Acid Hybridization”Prog. Nucleic Acid Res. Mol. Biol.11:259-301 (1971).
Ngo et al. “Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox” in The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. (eds.), Birkhauser Boston: Boston, MA, pp. 433 and 492-495 (1994).
Rudinger. “Characteristics of the Amino Acids as Components of a Peptide Hormone Sequence” in Peptide Hormones, Parsons (eds.), University Park Press: Baltimore, MD pp. 1-7 (1976).
Moore et al. “NLRX1 is a Regulator of Mitochondrial Antiviral Immunity”Nature451:573-579 (2008).
Accession No. AF389420,Homo sapiensNOD27 (NOD27) mRNA, complete cds; Source:Homo sapiens(Jun. 4, 2001).
Accession No. AF231021;Homo sapiensLeucine-Rich-Repeat Protein RNO2 mRNA, complete cds; Source:Homo sapiens; (2001).
Accession No. NM—033297;Homo sapiensNeuronal Apoptosis Inhibitor Protein 12 (NALP12), mRNA; Source:Homo sapiens(2003).
Accession No. AF526389;Homo sapienscryopyrin (CIAS1) gene, intron 6; Source:Homo sapiens(Jul. 2, 2002).
Accession No. AK025131;Homo sapienscDNA: FLJ21478 fis, clone COL05012; Source:Homo sapiens(Aug. 29, 2000).
Accession No. AK025212;Homo sapienscDNA: FLJ21559 fis, clone COL06406; Source:Homo sapiens.
Accession No. AK025362;Homo sapienscDNA: FLJ21709 fis, clone COL10077; Source:Homo sapiens(Aug. 29, 2000).
Accession No. AK027416;Homo sapienscDNA FLJ14510 fis, clone NT2RM1000623, weakly similar to Ribonuclease Inhibitor; Source:Homo sapiens(May 10, 2001).
Accession No. AK074109;Homo sapiensmRNA for FLJ00180 protein; Source:Homo sapiens(Jan. 21, 2002).
Accession No. AK074133;Homo sapiensmRNA for FLJ00206 protein, Source:Homo sapiens(Jan. 21, 2002).
Accession No. AK074182;Homo sapiensmRNA for FLJ00255 protein, Source:Homo sapiens(Jan. 21, 2002).
Accession No. AK090431;Homo sapiensmRNA for FLJ00348 protein; Source:Homo sapiens(Jul. 4, 2002).
Accession No. AK090439;Homo sapiensmRNA for FLJ00359 protein; Source:Homo sapiens(Jul. 4, 2002).
Accession No. AK090476;Homo sapiensmRNA for FLJ00398 protein; Source:Homo sapiens(Jul. 4, 2002).
Accession No. AK097030;Homo sapienscDNA FLJ39711 fis, clone SMINT2013032; Source:Homo sapiens(Jul. 4, 2002).
Accession No. AY051112;Homo sapienscryopyrin (CIAS1) gene, exon 1; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY051113;Homo sapienscryopyrin (CIAS1) gene, exon 2; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY051114;Homo sapienscryopyrin (CIAS1) gene, exon 3; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY051115;Homo sapienscryopyrin (CIAS1) gene, exon 5; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY051116;Homo sapienscryopyrin (CIAS1) gene, exons 7 and 8; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY051117;Homo sapienscryopyrin (CIAS1) gene, exon 9 and complete cds, alternatively spliced; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY056059;Homo sapienscryopyrin (CIAS1) gene, exon 4; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY056060;Homo sapienscryopyrin (CIAS1) gene, exon 6; Source:Homo sapiens(Aug. 15, 2001).
Accession No. AY092033;Homo sapiensNALP3 intermediate isoform (NALP3) mRNA, complete cds; Source:Homo sapiens(Mar. 27, 2002).
Accession No. AY116204;Homo sapiensmonarch-1 mRNA, complete cds; alternatively spliced; Source:Homo sapiens(May 29, 2002).
Accession No. AY116205; Accession No. AY116207;Homo sapiensmonarch-1 splice form II mRNA, complete cds; alternatively spliced; Source:Homo sapiens(May 29, 2002).
Accession No. AY116206;Homo sapiensmonarch-1 splice form III mRNA, complete cds; alternatively spliced; Source:Homo sapiens(May 29, 2002).
Accession No. AY116207;Homo sapiensmonarch-1 splice form IV mRNA, complete cds; alternatively spliced; Source:Homo sapiens(May 29, 2002).
Accession No. AY154469;Homo sapiensNALP14 (NALP14) mRNA, complete cds; Source:Homo sapiens(Sep. 25, 2002).
Accession No. BC013199;Homo sapiensNOD9 protein, mRNA (cDNA clone Image: 4387619), partial cds; Source:Homo sapiens(Aug. 27, 2001).
Accession No. NM—004895Homo sapienscold auto inflammatory syndrome 1 (CIAS1), transcript variant 1, mRNA; Source:Homo sapiens(2004).
Accession No. NM—024618;Homo sapiensNOD9 protein (NOD9), transcript variant 1, mRNA; Source:Homo sapiens(2003).
Accession No. NM—145827;Mus musculuscold auto inflammatory syndrome 1 homolog (human) (Cias 1), mRNA; Source:Mus musculus(2003).
Accession No. NM—170722;Homo sapiensNOD9 protein (NOD9), transcript variant 2, mRNA; Source:Homo sapiens(2003).
Accession No. NT—009325;Homo sapienschromosome 11 genomic contig; Source:Homo sapiens(2003).
Accession No. NT—009334;Homo sapienschromosome 11 working draft sequence segment; Source:Homo sapiens(Aug. 23, 2001).
Accession No. NT—015360;Homo sapienschromosome 16 working draft sequence segment; Source:Homo sapiens(Feb. 6, 2002).
Accession No. NT—024766;Homo sapienschromosome 16 working draft sequence segment; Source:Homo sapiens(Feb. 6, 2002).
Aganna, et al. 2002. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.Arthritis Rheum46:2445.
Akira, et al. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity.Nat Immunol2:675.
Alexopoulou, et al. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.Nature413:732.
Banerjee, et al. 2001. The leucine-rich repeat domain can determine effective interaction between RPS2 and other host factors inArabidopsisRPS2-mediated disease resistance.Genetics158:439.
Beg, et al. 1993. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.Mol Cell Biol13:3301.
Bertin and DiStefano. 2000. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins.Cell Death Differ. 7:1273.
Bertin, et al. 1999. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB.J Biol Chem274:12955.
Beutler, B. 2001. Autoimmunity and apoptosis: the Crohn's connection.Immunity15:5.
Bouchier-Hayes, et al. 2001. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways.J Biol Chem276:44069.
Brown, et al. 1998. The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.Nucleic.Acids.Res. 26:4128.
Buchanan and Gay. 1996. Structural and functional diversity in the leucine-rich repeat family of proteins.Prog Biophys Mol Biol. 65:1.
Chen and Goeddel. 2002. TNF-R1 signaling: a beautiful pathway.Science296:1634.
Cressman, et al. 1999. A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome.Immunity. 10:16
Conti Brian J.
Harton Jonathan A.
Linhoff Michael W.
Ting Jenny P.-Y
Williams Kristi L.
Burkhart Michael
Myers Bigel Sibley & Sajovec P.A.
The University of North Carolina at Chapel Hill
LandOfFree
Caterpiller gene family does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Caterpiller gene family, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Caterpiller gene family will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639405